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ing to induction of NF-kB (Reddy et al., 1994; MachleidtFederal Republic of Germany
et al., 1994). The domain of TNF-R55 initiating this
A-SMase pathway strikingly corresponds to the so-
called death domain responsible for mediating the cyto-
Summary toxic effects of TNF (Tartaglia et al., 1993b; Brakebusch
et al., 1992; Wiegmann et al., 1994). A second, equally
The initiation of intracellular signaling events through important, signaling pathway initiated by TNF-R55 in-
the 55 kDa tumor necrosis factor–receptor (TNF-R55) volves a membrane-bound neutral sphingomyelinase
appears to depend on protein intermediates that inter- (N-SMase; Kim et al., 1991; for review, see Kolesnick
act with specific cytoplasmic domains of TNF-R55. By and Golde, 1994; Pushkareva et al., 1995). Ceramide
combined use of the yeast interaction trap system production from hydrolysis of plasma membrane sphin-
and a peptide scanning library, the novel WD-repeat gomyelin results in activation of proline-directed protein
protein FAN has been identified, which specifically kinases, which might then be responsible for activation
binds to a cytoplasmic nine amino acid binding motif of phospholipase A2 (PLA2; Lin et al., 1993; Wiegmann
of TNF-R55. This region has been previously recog- et al., 1994). Arachidonic acid production by PLA2 ulti-
mately leads to the generation of proinflammatorynized as a distinct functional domain that is both re-
metabolites (reviewed by Heller and Kro¨nke, 1994). Pro-quired and sufficient for the activation of neutral sphin-
line-directed protein kinases might include a ceramide-gomyelinase (N-SMase). Overexpression of full-length
activated protein kinase (Liu et al.,1994), members of theFAN enhanced N-SMase activity in TNF–treated cells,
MAP kinase family (Vietor et al., 1993), and the stress-while truncated mutants of FAN produced dominant
activated protein kinase JNK-1 (Kyriakis et al., 1994).negative effects. The data suggest that FAN regulates
Recently, it has been shown that N-SMase mediatesceramide production by N-SMase, which is a crucial
TNF–induced activation of the protein kinase Raf-1 (Be-step in TNF signaling.
lka et al., 1995), possibly involving ceramide-activated
protein kinase (Yao et al., 1995) and thereby linking TNF-
Introduction R55 to the MAP kinase cascade. The domain within the
cytoplasmic domain of TNF-R55 responsible for initi-
Tumor necrosis factor (TNF), a cytokine produced ating this N-SMase pathway has been functionally
mainly by activated macrophages, mediates pleiotropic mapped to a small region directly adjacent to the death
inflammatory and immunoregulatory responses, as well domain and designated NSD (N-SMase activating do-
as cytotoxicity, antiviral activity, and stimulation of cell main; Adam et al., 1996).
growth (for review, see Goeddel et al., 1986; Beutler and Both TNF receptors belong to the nerve growth factor
Cerami, 1986; Fiers, 1991). These cellular responses to (NGF)/TNF-R superfamily, which includes among others
TNF are initiated by its interaction with two distinct cell- the Fas antigen, the lymphotoxin-b receptor, CD40, and
surface receptors of 55 kDa (TNF-R55) and 75 kDa (TNF- CD30 (for review, see Smith et al., 1994). Investigation
R75) apparent molecular mass, respectively, which of the intracellular events involved in the signal trans-
transmit signals to the cytoplasm and nucleus leading duction through members of the TNF receptor super-
to profound alterations in the transcriptional programs family has led to the identification of proteins directly
(for review, see Kro¨nke et al., 1992; Tartaglia and Goed- interacting with these receptors (for review, see Bazzoni
del, 1992; Rothe et al., 1992). Although several studies and Beutler,1995). So far, four proteins have been identi-
indicate that both TNF receptors are independently ac- fied that bind to TNF-R55. A novel protein, designated
tive in signaling TNF responses (Tartaglia et al., 1991; TRADD, requires the intact death domain to associate
Gehr et al., 1992; Barbara et al., 1994; Grell et al., 1994), with TNF-R55 (Hsu et al., 1995). In concordance, it has
a large majority of TNF activities can be mediated solely been shown that TRADD recruits FADD and RIP, two
other death domain–containing proteins (Chinnaiyan etby TNF-R55 (Espevik et al., 1990; Tartaglia et al., 1993a;
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al., 1995; Stanger et al., 1995) that trigger apoptosis, peptides 44–49, 59–60, and 65–67, containing amino
acids 331–357, 379–390, and 400–408, respectively,and that it also interacts with the RING finger protein
TRAF2 (Rothe et al., 1994) leading to NF-kB induction thereby confining an important binding region to amino
acids 331–408 (Figures 1B and 1C). This corresponds(Hsu et al., 1996a; 1996b). However, TNF-R55–associ-
ated proteins involved in initiating the N-SMase signal- well to the boundaries of the previously identified death
domain, spanning approximately amino acids 326–413ing pathway remained elusive.
In the present study, we report the isolation and char- (Tartaglia et al., 1993b). The N-terminal half of the TNF-
R55 cytoplasmic domain in general exhibited less bind-acterization of a novel protein, designated FAN (factor
associated with N-SMase activation), which associates ing activity that could be localized to three distinct sites
(at least 4-fold above background binding) on peptideswith the NSD of human TNF-R55. Sequence analysis
classifies FAN as a member of the family of WD-repeat 14–17, 26, and the NSD–containing peptide 36, con-
taining amino acids 245–268, 281–295, and 307–321,proteins, a growing family of regulatory proteins, many
of which are involved in signal transduction. Overex- respectively (Figures1B and 1C).Notably, theN-terminal
halves of human (Schall et al., 1990; Loetscher et al.,pression of FAN or of N-terminal FAN deletion mutants
demonstrates that FAN mediates TNF–induced activa- 1990) and mouse (Lewis et al., 1991) TNF receptor cyto-
plasmic domains show in general a lower degree oftion of N-SMase and, therefore, is likely to play an impor-
tant role in the regulation of major inflammatory cellular homology than the C-terminal halves. However, the
binding sites observed within the N-terminal half fall intoresponses to TNF.
the regions of greater conservation (Figure 1D).
Since a peptide scanning library clearly revealed a
Results linear protein binding motif precisely corresponding to
the functionally mapped NSD, we used a peptide library
Identification of a Novel TNF-R55–Associated staggered by only one amino acid each to identify NSD–
Protein That Binds to the NSD interacting proteins within the cohort of cDNA clones
To identify proteins that directly interact with the cyto- obtained by the yeast interaction trap system. Individual
plasmic domain of TNF-R55, we used the yeast interac- cDNAs were in vitro transcribed or translated, and the
tion trap system (Gyuris et al., 1993). Since we were resulting radiolabeled proteins were individually tested
especially interested in proteins that couple TNF-R55 for binding to the staggered peptides. One clone, desig-
to the N-SMase pathway, we fused a DNA fragment nated 73.31, showed specific binding to this region sig-
coding for amino acids 206–345 to the LexA DNA-bind- nificantly greater than background binding (Figure 2).
ing domain. Usingdeletion mutants of TNF-R55, we have We did not observe specific binding of clone 73.31 to
previously demonstrated that this region is sufficient to any other peptide outside the NSD throughout the entire
generate the N-SMase activating signal (Wiegmann et cytoplasmic region of TNF-R55 (data not shown). The
al., 1994). The TNF-R55 bait construct was used to minimally required amino acid content of the binding
screen a Jurkat cDNA expression library for interacting motif for this protein could be mapped to amino acids
proteins. A cohort of 18 clones was isolated that showed 310–318. Since our novel protein binds to amino acids
specific interaction with the cytoplasmic domain of TNF- within the motif previously demonstrated to be associ-
R55 (data not shown). ated with N-SMase activation (Adam et al., 1996), it was
To identify a cDNA clone or clones coding for a protein designated FAN. Sequence analysis of FAN(73.31) re-
or proteins that mediate the activation of the N-SMase vealed a partial cDNA insert of about 1 kb that by com-
pathway, we tookadvantage of our previouswork, which parison with the EMBL nucleotide sequence database
revealed a small region (amino acids 309–319), directly appeared to represent the 39-terminus of a novel gene.
adjacent to the death domain, which was necessary and A short 39-terminal stretch of FAN(73.31) was found to be
sufficient to activate N-SMase (NSD; Figure 1A; Adam et identical with randomly sequenced expressed sequence
al., 1996). To examine whether this functionally mapped tags, one of which was assigned to human chromosome
NSD contains binding sites for possible protein interac- 8 (Murakawa et al., 1994).
tion, we generated a cellulose-bound peptide scanning
library (Kramer et al., 1994; Weihergra¨ber et al., 1996) FAN Is a Ubiquitously Expressed WD-Repeat Protein
containing overlapping peptides of the entire cyto- Full-length coding sequence for FAN was obtained by
plasmic domain of TNF-R55 (Figure 1B). Jurkat cells screening human cDNA libraries with the partial cDNA
were metabolically labeled, and extracts were assayed fragment of clone FAN(73.31). Sequence analysis of this
for binding. The NSD (amino acids 309–319) strikingly cDNA clone revealed a 2751 bp open reading frame
corresponded to the strong binding site (7-fold above beginning with a translational initiation consensus se-
background binding) on peptide 36 containing amino quence (Kozak, 1987) and predicting a polypeptide of
acids 307–321 (Figures 1B and 1C). Since the neigh- 917 amino acids with a Mr of 104,312 (Figure 3A). The
boring peptides, 35 and 37 (amino acids 304–318 and 59-end was confirmed by additionally performed rapid
310–324), were both missing one amino acid at either amplification of cDNA ends–polymerase chain reaction
end, peptide 36 was the only one completely containing on human and mouse mRNA.
the functionally mapped NSD. In addition, at least five A comparison of the predicted amino acid sequence
more distinct regions werefound to bind proteins (Figure with the National Biomedical Research Foundation-PIR
1C). A set of three strong protein binding sites (at least databank revealedsignificant homologies with a number
5-fold above background binding) were found in the of WD-repeat proteins, including the human LIS-1 pro-
tein, the Drosophila transcription factor IID–associatedC-terminal half of the TNF-R55 cytoplasmic domain on
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Figure 1. Mapping of Protein Binding Sites
on the TNF-R55 Cytoplasmic Domain
(A) Schematic representation of functional
domains of TNF-R55.
(B) Overlapping peptides from the TNF-R55
cytoplasmic domain bound to continuous
cellulose membrane support.
(C) Protein binding domains of TNF-R55. 35S-
methionine–labeled protein extract from Jur-
kat cells was assayed for binding to the re-
ceptor-derived peptide scanning library.
Bound radioactivity was visualized by autora-
diography and quantified using laser densi-
tometer scanning of the autoradiographs. Re-
gions of increased binding activity (at least
4-fold above background binding) are boxed
and marked by Roman numerals.
(D) Homology plot of amino acids 202–326 of
the human TNF-R55 (Loetscher et al., 1990)
and the mouse TNF-R55 (Lewis et al., 1991).
Colons mark identical amino acids; periods
mark conservative changes. The binding do-
mains identified in (C) are boxed and marked
by corresponding numerals.
protein, and the yeast TUP-1 gene product (reviewed 1990; Loetscher et al., 1990) and is consistent with FAN
involvement in TNF-R55 signal transduction. The appar-by Neer et al., 1994). Further analysis showed that the
C-terminus of FAN contained five WD-repeats (Figure ent size of the FAN mRNA of 3.8 kb corresponds to the
length of the isolated cDNA clones.3B). None of these WD-repeats had more than four mis-
matches within its core sequence spanning 29–31 amino
acids, consistent with the range of 23–41 amino acids FAN Specifically Interacts with the NSD of TNF-R55
Specific interaction of the entire FAN protein (aminoin other members of this class of proteins (Neer et al.,
1994). Interestingly, the growing family of WD-repeat acids 3–917) as well as of the truncated FAN protein
(FAN[73.31], amino acids 703–917) with the NSD of TNF-proteins appears to be composed mostly of regulatory
proteins, some of them involved in signal transduction R55 was demonstrated in additional yeast interaction
trap experiments. Full-length or truncated FAN fused to(Neer et al., 1994). In addition, the N-terminus of FAN has
significant homology to a human protein homologous to the transcriptional activation domain was coexpressed
with various TNF-R55 deletion mutants or a panel ofyeast CDC4 (Feuchter et al., 1992), a WD-repeat protein
of unknown function. unrelated proteins fused to the LexA DNA-binding do-
main (Table 1). Both full-length and truncated FAN(703–Northern blot analysis revealed that the mRNA encod-
ing FAN is expressed in a wide variety of human tissues 917) strongly interacted with TNF-R55 constructs con-
taining the NSD. As expected, the cytoplasmic domain(data not shown). This expression pattern corresponds
to the ubiquitous expression of TNF-R55 (Schall et al., of the deletion mutant TNF-R55D308–340 lacking the
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Figure 2. Clone 73.31 Binds Specifically to Peptides Containing the
N-SMase Activation Domain
The cDNA of clone 73.31 was in vitro transcribed or translated,
and the radiolabeled protein was incubated with a receptor-derived
cellulose-bound peptide scanning library. The binding activity re-
sulting from laser densitometer scanning of autoradiographs is
shown for peptides containing the indicated amino acids in compari-
son with a nonspecific protein (clone 39.1) used as a control.
NSD (Adam et al.,1996) failed completely to interact with
full-length or truncated FAN. Control baits consisting of
either the unrelated protein tyrosine kinase SYK or re-
Figure 3. Predicted Amino Acid Sequence of FAN Showing Fivelated membrane receptors such as TNF-R75, Fas, and
WD-Repeatsthe Interleukin-1 receptor did not associate with the FAN
(A) The amino acid sequence deduced from the sequence of a cDNAproteins. FAN(703–917) fused to the LexA DNA-binding
clone isolated by screening a human muscle cDNA library with thedomain showed a minor constitutive transactivating ef-
1 kb cDNA fragment of clone 73.31. The WD-repeats are underlined,
fect in yeast by itself, even without an activation-domain and the 59-ends of the deletion mutants (FAN[448–917] and
partner. This effect, however, was significantly en- FAN[703–917]) are indicated.
hanced in the presence of the TNF-R55D345 cyto- (B) Alignment of the five WD-repeats located in the C-terminus of
FAN. The WD-consensus sequence according to Neer et al. (1995)plasmic domain fused to the activation domain, confirm-
is shown above. Mismatches in the FAN repeats are indicated ining specific interaction of FAN and TNF-R55. Taken
bold.together, the interaction trap assay strongly suggested
a highly specific interaction between FAN and TNF-R55,
strictly requiring the presence of the NSD. The NSD–
Taken together, these results confirm the specific inter-binding site of FAN is apparently located within the
action of FAN and TNF-R55 in intact cells.C-terminal WD-repeat region (703–917).
To demonstrate physical interaction between FAN
and TNF-R55 in intact cells, we left COS-1 cells un-
FAN Mediates Activation of N-SMasetransfected or transfected with the FLAG-tagged full-
To address the role of FAN for theactivation of N-SMase,length FAN fusion construct or the vector pFLAG.CMV2.
we investigated the ability of the NSD–derived pep-Identical amounts of cellular lysates were immunopre-
tide containing amino acids 307–321 (D2A) to interferecipitated using the a–TNF-R55 monoclonal antibody
with TNF–induced sphingomyelin hydrolysis. Increasinghtr-9 or an isotype-matched monoclonal control anti-
amounts of the peptide D2A or a control peptide con-body against human CD28. The reactivity of htr-9 with
taining death domain–derived amino acids (E2A) weresimian TNF-R55 was previously confirmed by FACS
incubated with membrane fractions of Jurkat cells prioranalysis (data not shown). Western blotting with the
to TNF treatment. As shown in Figure 5, N-SMase activa-a-FLAG antibody MAb5 detected a protein of approxi-
tion was effectively inhibited by peptide D2A but notmately 100 kDa, corresponding to the predicted size of
by the control peptide. Thus, the NSD–derived peptidethe FLAG–FAN fusion protein, only in FLAG-FAN–
specifically blocked the activation of N-SMase, probablytransfected cells immunoprecipitated with the a–TNF-
owing to competitive binding of FAN, which providesR55 antibody htr-9 (Figure 4). FLAG–FAN was detected
the first means of selective and specific interferenceneither in immunoprecipitations with the control anti-
with N-SMase activation.body, nor in lysates from cells transfected with the vec-
tor pFLAG.CMV2 or from untransfected cells (Figure 4). To demonstrate directly the involvement of FAN in the
Novel WD-Repeat Protein Interacts with TNF-R55
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Table 1. Specific Interactions between FAN and TNF-R55
Growth on Relative b-Galactosidase
DNA-binding–domain hybrida Activation-domain hybrid Leu2 mediumb Colony color activityc
TNF-R55 (aa 206–345) – 2 White ,1
– TNF-R55 (aa 206–345) 2 White ,1
TNF-R55 (aa 206–345) FAN (aa 703–917) 1 Blue 27.3
TNF-R55 (aa 206–345) FAN (aa 3–917) 1 Blue n.d.
TNF-R55 (aa 206–426) FAN (aa 703–917) 1 Blue 24.7
TNF-R55 (aa 206–426) FAN (aa 3–917) 1 Blue n.d.
TNF-R55 (D 308–340) FAN (aa 703–917) 2 White ,1
TNF-R55 (D 308–340) FAN (aa 3–917) 2 White n.d.
SYK FAN (aa 3–917) 2 White n.d.
FAS (aa 191–335) FAN (aa 3–917) 2 White n.d.
TNF-R75 (aa 288–461) FAN (aa 3–917) 2 White n.d.
IL1-R (aa 342–557) FAN (aa 3–917) 2 White n.d.
FAN (aa 703–917) – (1)/2 Light blue 4.0
FAN (aa 703–917) TNF-R55 (aa 206–345) 1 Blue 36.1
a Yeast cells were sequentially transformed with expression vectors encoding various lexA DNA-binding domain and activation domain fusion
proteins.
b Each double transformant was plated on Ura2His2Trp2Leu2 galactose plates and on Ura2His2Trp2 galactose plates containing X-Gal.
c At least 100 colonies each were combined, grown in liquid culture, and b-galactosidase activity was measured in triplicate as described in
Experimental Procedures.
activation pathway of N-SMase, we transiently cotrans- stimulated cells transfected with FAN(703–917) or com-
plete FAN corresponded to the changes of N-SMasefected COS-1 cells with pEF.CD4, containing only extra-
cellular and transmembrane portions of CD4 to avoid activities (Figure6B).Measurementsofceramidesteady-
state levels, however, may not precisely reflect N-SMaseany functional interference, together with expression
constructs containing cDNAs either encoding the com- activities, because ceramide can be rapidly metabolized
to ceramide-1-phosphate, sphingosine, or gangliosides.plete FAN protein, an N-terminal deletion mutant FAN
(703–917), or a C-terminal deletion mutant FAN(1–547). In addition, ceramide can be produced by other SMases
like A-SMase or by ceramide synthase. The effects ofTransfected cells were enriched by a magnetic column
after staining with a-CD4 magnetic beads. Cells ex- TNF on enzymes involved in ceramide metabolism are
not known. As a minimal approach, cells have beenpressing the C-terminal 215 amino acids of FAN (amino
acids 703–917), containing WD-repeats 2–5 (see Figure pretreated with D609, which has been shown to prevent
ceramide production by a TNF–responsive A-SMase ac-3B) exhibited a dominant negative effect on N-SMase
activation by TNF (Figure 6A). In contrast, cells ex- tivity (Schu¨tze et al., 1992).
To investigate the specificity of FAN action, enzymaticpressing the complete FAN protein showed enhanced
N-SMase activation. The C-terminal deletion mutant activities of A-SMase and N-SMase were measured in
FAN(1–547) did not influence theTNF–induced N-SMase
activation. The basal level of N-SMase activity without
TNF treatment remained unchanged in all transfected
cells, and the expression of the different FAN proteins
did not lead to a different kinetics of TNF–induced
N-SMase activation (Figure 6A). Ceramide levels in TNF–
Figure 5. The Peptide Containing the FAN Binding Motif Specifically
Suppresses N-SMase Activation
Figure 4. Association of TNF-R55 and FAN in Intact Cells Membrane fractions of Jurkat cells were obtained by mild lysis (see
Experimental Procedures) and left untreated or incubated for 30COS-1 cells (1 3 107) were left untransfected or were transiently
transfected with 20 mg of pFLAG.CMV2 or pFLAG.FAN(3–917). After min, with the indicated amounts of peptide D2A containing the FAN
binding motif or with a death domain–derived control peptide (E2A).48 hr, cells were lysed and cellular lysates were immunoprecipitated
with the a–TNF-R55 antibody htr-9 or an isotype-matched control After stimulation for 0 or 1.5 min with TNF, N-SMase activity was
measured at pH 7.4. TNF–induced N-SMase activities are expressedantibody (a-CD28). Western blots were performed with the a–FLAG-
antibody MAb5. The coprecipitating FLAG–FAN fusion protein is in production of phosphorylcholine [pmol 3 mg21 3 h21]. Shown are
values of one representative experiment (n 5 3); the bars indicateindicated by an arrow. The positions of molecular mass markers (in
kDa) are indicated on the left. the respective standard deviations from triplicate determinations.
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942
parallel in COS-1 cells transiently transfected with FAN
or a truncated version of FAN. Neither an N-terminal
deletion mutant FAN(448–917) nor the entire FAN pro-
tein had any effect on A-SMase activation after TNF
treatment (Figure 6C). Similar to the results shown in
Figure 6A, expression of FAN(448–917)exhibited a domi-
nant negative effect on TNF–induced N-SMase acti-
vation, while complete FAN enhanced TNF–induced
N-SMase activation (Figure 6C). FAN-induced changes
of N-SMase activities were less pronounced when com-
pared with Figure 6A, because transfectants were not
enriched by CD4.
Taken together, our results clearly show that the inter-
action of FAN with the NSD is responsible for mediating
TNF–induced N-SMase activation, while the A-SMase
pathway remains unaffected.
Discussion
During the last few years, the intracellular events by
which TNF-R55 transmits signals through the cell mem-
brane into cytoplasm and nucleus after ligand binding
have begun to be elucidated. There are two major path-
ways that have been shown to involve phospholipases:
the A-SMase pathway and the N-SMase pathway, both
leading to different cellular responses (Wiegmann et al.,
1994). The structural motifs within the cytoplasmic do-
main of TNF-R55 initiating these signals have been iden-
tified: a C-terminal domain signals the A-SMase path-
way (Wiegmann et al., 1994), which seems to be identical
to the death domain–signaling apoptosis (Brakebusch
et al., 1992; Tartaglia et al., 1993b). Another functional
domain, the N-terminal NSD, is responsible for the
N-SMase pathway (Adam et al., 1996). However, direct
links between TNF-R55 and N-SMase, which could pro-
vide hints on the activation mechanisms, have not been
Figure 6. FAN Mediates N-SMase Activation described yet.
(A) COS-1 cells (1 3 107) were transiently cotransfected with 20 mg Here we describe a novel protein, FAN, that is shown
of pEF.CD4 and with either 20 mg of the control vector (pEF.ATG, to interact with human TNF-R55. By use of the yeast
open square) or 20 mg of the indicated FAN expression constructs interaction trap system, we demonstrate that binding of
(closed circle). After 24 hr, transfected cells were enriched by a-CD4
FAN to TNF-R55 is highly specific and does require thestaining followed by magnetic purification. After an additional 24 hr,
presence of the NSD. The specific binding of FAN tocells were treated in triplicate with 100 ng/ml of TNF for the indi-
NSD–containing peptides suggests that, in contrast tocated times, and N-SMase activity was determined. TNF–induced
N-SMase activities are expressed as percent of untreated vector- proteins binding to the death domain, the tertiary struc-
transfected cells. Basal levels of phosphorylcholine production were ture of TNF-R55 does not seem to play an important
234–242 pmol 3 mg21 3 h21. The results are representative for three role for interaction with FAN. The binding motif for the
independent experiments.
association between FAN and TNF-R55 was mapped to(B) COS-1 cells (2 3 107) were transiently cotransfected with 20 mg
amino acids 310–318, which corresponds perfectly toof pEF.CD4 together with 20 mg of pEF.ATG or with 20 mg of the
the functionally mapped NSD (amino acids 309–319;indicated FAN expression constructs. After 24 hr, transfected cells
were enriched by a-CD4 staining followed by magnetic purification. Adam et al., 1996). The interaction of FAN and TNF-R55
After an additional 24 hr, cells were treated in triplicate with 100 was confirmed in intact cells by coimmunoprecipitation
ng/ml of TNF for 1.5 min, and ceramide steady-state levels were of transfected FLAG-tagged full-length FAN with the
determined. The results are representative for three independent
endogenous TNF-R55 of COS-1 cells. A synthetic NSD–experiments.
derived peptide competes for binding of a signal-trans-(C) COS-1 cells (1 3 107) were transiently transfected with 20 mg of
ducing protein or proteins and thereby completely inhib-pEF.ATG or with the indicated FAN expression constructs. After 48
hr, cells were treated in triplicate with 100 ng/ml of TNF for 1.5 min its N-SMase activation. This underscores the essential
for N-SMase assays or 3 min for A-SMase assays, and N-SMase role of the NSD and the NSD–binding protein FAN for
activity at pH 7.4 or A-SMase activity at pH 5.0 was determined. the initiation of the N-SMase pathway. Moreover, over-
TNF–induced SMase activities are expressed as percent of un-
expression of full-length FAN enhances N-SMase acti-treated vector-transfected cells. Basal levels of phosphorylcholine
vation in a TNF–dependent manner, while N-terminalproduction were [mg21 3 h21]: 133–194 pmol for N-SMase and 582–
truncations of FAN that retain only the TNF-R55 bind-670 pmol for A-SMase. The results are representative for three inde-
pendent experiments, respectively. ing WD-repeats are dominant-negative inhibitors of
Novel WD-Repeat Protein Interacts with TNF-R55
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Structure of FAN
Sequence analysis of the predicted open reading frame
encoding FAN revealed its structural homology to the
family of WD-repeat proteins (for review, see Neer et
al., 1994). These proteins have in common the presence
of at least four WD-repeats. All so far described WD-
repeat proteins appear to serve regulatory functions in
various cellular processes. Notably, none of them con-
tains an intrinsic enzymatic function. Many WD-repeat
proteins are involved in signal transduction, such as the
b-chains of heterotrimeric G proteins (Watson et al.,
1994), RACK1 (Ron et al., 1994), the PLA2-activator pro-
tein (PLAP; Clark et al., 1991), the regulatory subunit of
phosphatase 2A (Mayer et al., 1991), or the recently
described protein associated with the type II TGF-b–
receptor (Chen et al., 1995). Some of them consist only
of WD-repeats (for example, RACK1; Ron et al., 1994),
others contain N- or C-terminal extensions of various
lengths (for example, PLAP; Clark et al., 1991). The WD-
repeat structure seems to be a functional motif that may
facilitate defined protein–protein interactions, some-
times leading to multiprotein complexes, as shown forFigure 7. TNF-R55 Initiates the N-SMase Pathway via Interaction
the b-subunit of heterotrimeric G proteins (Neer et al.,between the NSD and FAN
1994). The additional amino acid sequences may con-NSD, N-SMase activation domain. DD, death domain. The amino
tribute to the regulatory function. This has been shownacid sequence of the FAN binding motif is indicated.
for the PLA2-activator protein, PLAP, in which a short
region in the C-terminal extension activates PLA2 (ClarkN-SMase activation. Interestingly, a C-terminal deletion
et al., 1991). This modular structure might also apply tomutant of FAN lacking the WD-repeats required for inter-
FAN. The region of FAN required for association withaction with TNF-R55 was unable to influence the TNF–
TNF-R55 has been mapped to the C-terminal 214 aminoinduced N-SMase activation when overexpressed in
acids, since this portion of FAN is sufficient to interactCOS-1 cells. This suggests that the function of FAN may
with TNF-R55 in the yeast interaction trap system. Withinrequire binding to TNF-R55, which is mediated by the
this region, four out of five WD-repeats are located,C-terminal WD-repeats of FAN. A possible explanation
suggesting that the interaction with TNF-R55 is medi-for the TNF–dependence of FAN function could be that
ated by the WD-repeats. The expression of a trun-binding of FAN to TNF-R55 requires oligomerization of
cated FAN molecule, containing only the WD-repeatsthe receptor after ligand binding. The interaction of FAN
(FAN[448–917]), acts in a dominant-negative manner onwith the aggregated TNF-R55 might then induce a con-
TNF–induced N-SMase activation, suggesting that itformational change in FAN that is not achieved solely
lacks an effector domain in the N-terminus. However,by overexpressing FAN or by binding of FAN to the
TNF-R55 binding seems to be required for the functioncompeting peptide. FAN action is apparently strictly
of FAN, since expression of the C-terminal FAN deletionspecific for N-SMase, since none of the FAN constructs
mutant containing amino acids 1–547 by itself had noshowed any effect on the activation of A-SMase. To-
effect on either the basal level of the N-SMase activitygether, our data indicate that FAN represents an impor-
or on the TNF–induced N-SMase activation. The se-tant functional intermediate between the TNF-R55 and
quence of the putative FAN effector domain spanningthe activation of N-SMase (Figure 7).
the 627 amino acids N-terminal of the WD-repeats doesIt should be emphasized that FAN is clearly distinct
not provide any evidence for potential enzymatic activi-from any other TNF-R55–associated protein so far de-
ties of FAN. The N-terminal extension of FAN sharesscribed. Characterizations of TRADD (Hsu et al., 1995)
a sequence homology of amino acids 304–575 (53.8%and, in turn, TRADD–associated proteins (Hsu et al.,
sequence identity) with another human WD-repeat pro-1996a; 1996b), have provided a possible link of the death
tein of unknown function (Feuchter et al., 1992), whichdomain with the activation of PC-PLC, A-SMase, induc-
suggests the existence of a family of FAN-related pro-tion of NF-kB, and apoptosis. Despite the identification
of proteins binding to TNF-R55 outside the death do- teins.
main, none of these proteins can provide a possible link
between the NSD and activation of N-SMase. TRAP1
Biological Implications of FAN-Associatedand TRAP2, proteins that possess sequence homology
Nonapoptotic Signalsto the 90 kDa family of heat-shock proteins, display
While a more detailed picture is beginning to emergebinding properties not consistent with binding to the
for the signals leading to the A-SMase/apoptotic path-functionally defined NSD (Song et al., 1995). The binding
way by identifying the death domain and its major inter-site of TNF-R55 for a protein with homology to the yeast
action partners (Tartaglia et al., 1993b; Hsu et al., 1995,equivalent of the p112 subunit of the 26S proteasome
1996a, 1996b), the N-SMase pathway has been investi-(55.11) has been mapped to amino acids 243–308, up-
stream of the NSD (Boldin et al., 1995). gated less intensively. We have recently suggested a
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b-mercaptoethanol, and 50 mg/ml each of streptomycin and penicil-sequential activation of N-SMase, proline-directed pro-
lin. Highly purified recombinant human TNF (3 3 107 U/mg) wastein kinases, and PLA2 as an independent signaling cas-
provided by G. Adolf (Boehringer Research Institute). The a–TNF-cade (Wiegmann et al., 1994). This N-SMase pathway
R55 monoclonal antibody htr-9 (Brockhaus et al., 1990) was a gift
involves the activation of various important signaling from W. Lesslauer and H. Loetscher, and the a-CD28 monoclonal
systems. Activation of membrane-bound N-SMase itself antibody was purchased from Dianova. The monoclonal a–FLAG-
antibody (MAb5) was purchased from Kodak International Biotech-is a very early step in TNF-R55 signaling, leading to
nologies. Peptides were synthesized using an automated synthe-production of thesecond messenger moleculeceramide
sizer (Abimed) according to the standard Fmoc machine protocols.(Dressler et al., 1992; Wiegmann et al., 1994). Ceramide
After cleavage of the protection groups, the products were purifiedproduction by N-SMase has been shown to lead to a
by High Pressure Liquid Chromatography to greater than 95%.
sequential activation of a ceramide-activated kinase,
ceramide-activated protein kinase (Liu et al., 1994), raf-1 Plasmid Construction
kinase (Belka et al., 1995; Yao et al., 1995), and MAP The LexA DNA-binding domain fusions were constructed in the
vector plex202 (a gift from R. Brent). The cytoplasmic domains ofkinases (Vietor et al., 1993). The MAP kinase cascade
the human TNF-R55 and the D345 and D308–340 deletion mutantsrepresents an essential pathway of mitogenic signaling
were cloned by polymerase chain reaction into plex202. The cDNAsin many cell types. The activation of MAP kinases by
of human TNF-R75, human Fas antigen, and mouse Interleukin-1
raf-1 could thus explain the growth-stimulatory function receptor were provided by A. Himmler (Boehringer Research Insti-
of TNF observed in select cell types (Vietor et al., 1993). tute), M. Peter, and W. Falk, respectively. The corresponding cyto-
One important proinflammatory enzyme downstream of plasmic domains were cloned by polymerase chain reaction into
plex202. The plex.SYK construct was obtained by cloning the entireMAP kinase is PLA2. MAP kinase activates PLA2 by phos-
coding sequence for the protein tyrosine kinase SYK into plex202phorylation (Lin et al., 1993), which leads to production
restricted by MluI/NotI. The generation of the Jurkat cDNA libraryof arachidonic acid and finally to the secretion of pro-
fused to a synthetic activationdomain has been describedelsewhere
staglandine E2 and leukotrienes, important mediators of (Stanger et al., 1995). The plex.FAN constructs were generated by
the inflammatory response (for review, see Heller and cloning FAN cDNAs containing amino acids 3–917 and 703–917,
Kro¨nke, 1994). Similar observations have been recently respectively, into plex202. For in vitro transcription or translation,
the cDNA inserts isolated from clones derived from the two-hybridreported for the signaling through the Fas antigen, an-
screen were subcloned into pBluescript.KS1 (Stratagene). For theother member of the TNF receptor superfamily. Analo-
in vivo interaction assay, the FAN cDNA containing amino acidsgous to the functional dichotomy of TNF-R55, Fas initi-
3–917 was subcloned into pFLAG.CMV2 (Kodak International Bio-
ates an A-SMase pathway, which was linked to the technologies). For eukaryotic expression studies, the vector pEF.
cytotoxic signal of Fas. Like TNF-R55, Fas indepen- ATG was constructed by inserting an oligonucleotide containing a
dently signals for an N-SMase pathway, leading to acti- start codon in-frame with an EcoRI site followed by a NotI site into
pEF.BOS (Mizushima and Nagata, 1990), cut with EcoRI and blunt-vation of the MAP kinase ERK2 and of PLA2 (Cifone et
ended with Klenow polymerase. Complete or truncated FAN cDNAsal., 1995). Although the Fas antigen does not contain
were subcloned from phagemid clones isolated by hybridizationthe FAN-binding motif and does not interact with FAN
screening of cDNA libraries into pEF.ATG. The pEF.CD4 expression
(Table 1), it harbors a region immediately upstream of construct was generated by amplifying the extracellular and trans-
its death domain (S. A.-K. etal., unpublished data), which membrane domains of the human T cell surface molecule CD4 by
displays minimal homology to the NSD of TNF-R55 and polymerase chain reaction and cloning into pEF.BOS.
which might serve as binding motif for a FAN-related
Yeast Interaction Trap Systemprotein.
Transformation of the yeast strain EG48/JK103 (Gyuris et al., 1993)We have previously shown that the signaling cas-
with bait constructs and, subsequently, with the library DNA orcades initiated by the death domain do not overlap with
selected activation domain fusion constructs, was performed as
the N-SMase pathway (Wiegmann et al., 1994). Indeed, described (Stanger et al., 1995). Transformants were grown on Ura2
FAN does not seem to interfere with death-domain sig- His2Trp2 glucose plates, before selection for leucine prototrophy
naling. None of the FAN expression constructs had any on Ura2His2Trp2Leu2 galactose plates was used to test for positive
interaction. Testing for b-galactosidase expression was performedeffect on TNF–induced CAT gene transcription directed
either on Ura2His2Trp2 galactose X-Gal plates or, for quantitation,from four HIV–related kB sites (data not shown). Neither
in a liquid assay. Yeast cells were grown overnight at 308C in Ura2expression of FAN nor expression of FAN deletion mu-
His2Trp2 galactose medium to an OD600 of about 1.8, diluted 1:5 intants changed the cytotoxic action of TNF (data not the same medium and grown at 308C to an OD600 of 1.5 to 1.8. Cells
shown). were washed twice in phosphate-buffered saline (PBS), lysed in
Taken together, our results indicate that FAN is a novel PBS by freezing/thawing, anddiluted 1:8 with PBS containing0.36%
b-mercaptoethanol. The reaction was started by adding 160 ml ofWD-repeat protein that is distinct from death domain–
PBS containing 2.8 mg/ml of o-nitrophenyl-b-D-galactoside andassociated proteins and any other TNF-R55–binding
stopped after incubation for 90 min at 378Cwith 400ml of 1M NA2CO3.protein so far described. Instead, FAN appears to be
After precipitating the cells, the absorbance at 429 nm of the super-
crucially involved in mediating TNF–induced activation natants was determined. b-galactosidase units were calculated
of the N-SMase pathway, which in turn regulates impor- by the equation: units 5 OD420 3 1000/(time [min.] 3 vol. [min.] 3
tant mitogenic and proinflammatory responses. O D600).
Protein Binding to a TNF-R55–Derived Cellulose-Bound
Peptide Scanning LibraryExperimental Procedures
The TNF-R55–derived peptide scanning libraries were automatically
prepared by spot synthesis (Frank, 1992) using a spot synthesizerCell Culture and Biological Reagents
The human leukemic T cell line Jurkat and COS-1 cells were origi- (Abimed) and the software DIGEN (Jerini Bio Tools), as described
in detail elsewhere (Kramer et al., 1994; Reineke et al., 1996). Wenally obtained from the American Type Culture Collection. All cell
lines weregrown in Click’s RPMI culture medium (Biochrom)supple- prepared two different scans covering the entire cytoplasmic do-
main of TNF-R55: one library containing 15 mer (12 amino acidsmented with 10% fetal calf serum, 10 mM glutamine, 0.1 mM
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overlapping) and a second library consisting of 13 mer (11 amino Ceramide Quantitation
COS-1 cells were cotransfected with pEF.CD4 and various FANacids overlapping). To generate radiolabeled whole-cell extracts
from Jurkat cells, 3 3 107 cells were incubated with 2.5 mCi in vitro expression constructs and enriched for CD4-expressing cells after
24 hr. After a further 24 hr, cells were treated with 50 mg/ml of D609cell labeling mix (Amersham; more than 1000 Ci/mmol of L-[35S]-
methionine and L-[35S]-cysteine) in methionine/cysteine-free me- for 30 min to prevent the activation of A-SMase (Schu¨tze et al.,
1992). Thereafter, cells were stimulated with TNF. Ceramide wasdium for 4 hr, washed twice in PBS, and lysed in HDP (30 mM HEPES
[pH 7.9], 10% glycerol, 7 mM MgCl2, 10 mM KCl, 1 mM dithiothreitol, quantitated by thediacylglycerol kinase assayas described by Dres-
sler and Kolesnick (1990). Cells were extracted with chloroform :0.1% NP40, 10 mg/ml of aprotinin and leupeptin) by freezing/thaw-
ing. The cell lysate was incubated on peptide filters, prewashed methanol : 1N HCl (100 : 100 : 1, v/v/v), and lipids were dried under
N2. The extracts were incubated with 0.1 N methanolic KOH for 1twice in methanol and twice in PBS in 1 3 blocking reagent (Cam-
bridge Research Biochemicals) and in HDP overnight at 48C with hr at 378C to remove glycerophospholipids. After reextraction, the
organic phase was dried under N2. Ceramide was measured usingcontinuous shaking. After five washes at room temperature in NET
(150 mM NaCl, 50 mM Tris [pH 7.5], 5 mM EDTA, 0.05% NP40), the sn-1,2-diacylglycerol (DAG) assay reagents system (Amersham),
following the protocol provided by the manufacturer. Ceramidefilters were air-dried and autoradiographed. Radiolabeled proteins
encoded by the clones derived from the interaction trap screening 1-phosphate levels were determined by two-dimensional laser den-
sitometry of autoradiographs. Ceramide levels were quantified bywere generated using the TNT T7-coupled Reticulocyte Lysate Sys-
tem (Promega) and 35S-methionine (Amersham). Screening of the comparison with a standard curve of ceramide 1-phosphate gener-
ated by subjecting 30–500 pmol of ceramide (ceramide type III,peptide libraries with the in vitro translated proteins was performed
as described above. Sigma) to the DAG kinase reaction.
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